Metraipolis › archive › dc_337283f39c41

Formulation and Comparative Characterization of SLNs and NLCs for Targeted Co-Delivery of Paclitaxel and Hydroxytyrosol Carboxylic Acid Esters Against… — Europe PMC PMID:41012543

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/41012543
DOI: 10.3390/pharmaceutics17091208
License (as archived): solo-consultazione
Archived: 2026-11-09T22:46:49.320Z
SHA-256 of the archived text: 0c43ca46860718cf459f70b161f4f302a31489184437c8acbe64d579d329b16a
Stable URL of this page: https://metraipolis.com/documento/dc_337283f39c41

How to cite

Formulation and Comparative Characterization of SLNs and NLCs for Targeted Co-Delivery of Paclitaxel and Hydroxytyrosol Carboxylic Acid Esters Against… — Europe PMC PMID:41012543 — Europe PMC (en), https://europepmc.org/article/MED/41012543 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_337283f39c41 (Metraipolis archive dc_337283f39c41, sha256 0c43ca46860718cf459f70b161f4f302a31489184437c8acbe64d579d329b16a)

BibTeX

@misc{dc337283f39c41,
  title = {Formulation and Comparative Characterization of SLNs and NLCs for Targeted Co-Delivery of Paclitaxel and Hydroxytyrosol Carboxylic Acid Esters Against… — Europe PMC PMID:41012543},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41012543},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_337283f39c41; sha256 0c43ca46860718cf459f70b161f4f302a31489184437c8acbe64d579d329b16a},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41012543. Agents can read the archived copy with the MCP tool read_document.